Jobs
-
Alexza Pharmaceuticals has announced interim results from a Phase 2a study of AZ-002 inhaled alprazolam in epilepsy patients. Dose-related decreases in mean standardized photosensivity range (SPR), the study’s primary endpoint, were noted 2 minutes post… Read more . . .
-
A study published online in the journal Diabetes Care on December 17, 2015 demonstrated non-inferiority of intranasal glucagon to intramuscular glucagon for the treatment of insulin-induced hypoglycemia in type 1 diabetes patients. The study found… Read more . . .
-
After the arrest of its CEO, Martin Shkreli, on securities fraud charges, Turing Pharmaceuticals has announced Shkreli’s resignation and the appointment of Ron Tilles as Interim CEO. Tilles has chaired Turing’s board of directors since… Read more . . .
-
AstraZeneca has announced that it will acquire Takeda’s respiratory line for $575 million. According to the company, about 200 Takeda employees will transfer to AstraZeneca as part of the deal. The company is citing the… Read more . . .
-
Turing Pharmaceuticals CEO Martin Shkreli has been arrested by the Federal Bureau of Investigations for securities fraud involving illegal stock transactions when he was CEO of Retrophin Pharmaceuticals. Retrophin fired Shkreli in September 2014 and… Read more . . .
-
Capsugel has announced that it will acquire CDMO Xcelience and micronization services provider Powdersize in order to “enhance Capsugel’s position as a leading provider of innovative dosage forms and solutions to healthcare customers around the… Read more . . .
-
Novartis, East Hanover, NJ Job requirements Independently, provide and drive strategic and operational global CMC regulatory direction and documentation for complex projects/products covering development, registration and approval/post approval activities as assigned. As a senior member… Read more . . .
-
UK-based CDMO Pharmaterials Ltd has announced the promotions of Chris Landeg to VP, Operations and Martin Wing-King to Director, Business Development and Project Management. The company also said that it has hired Yogesh Davé as… Read more . . .
-
Teva has acquired exclusive marketing and commercialization rights to Egalet Corporation’s Sprix ketorolac tromethamine nasal spray in Israel, Gaza and the West Bank, Egalet has announced. Sprix nasal spray is used for the short-term treatment… Read more . . .
-
Dry powder inhalation products developer Pulmatrix has appointed former Civitas Therapeutics CEO Mark Iwicki as chairman of its board of directors, the company said. Iwicki has also previously headed Blend Pharmaceuticals and Sunovion and currently… Read more . . .
Featured event:
Upcoming Events
Sponsored by Intertek,, hosts of
The Inhaled & Nasal Biologics | DNA Forum
Want information about upcoming OINDP-related events delivered directly to your inbox? click here
September 15-September 18: DDL New Researcher Network Summer Event, London, UK
September 16-September 17: IPAC-RS 2026 Nasal Innovation Forum, Jersey City, NJ, USA
September 24-September 25: Inhaled & Nasal Biologics | DNA Forum, Cambridge, UK
October 14-October 15: Advancing Bioequivalence Frameworks for Inhalation and Nasal Drug Products: Optimizing In Vitro, In Vivo, and In Silico Methods, Rockville, MD, USA
October 19-October 20: MVIC Autumn Training 2026, Lund, Sweden